Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Seurat Technologies | 2023 | Series C | $99.0M | Wilmington |
| Evozyne | 2023 | Series B | $81.0M | Chicago |
| CHARM Therapeutics | 2023 | Venture - Series Unknown | $20.0M | London |
| vitrealab | 2026 | Series A | $11.0M | Vienna |
| Freeform | 2026 | Venture - Series Unknown | $58.9M | Los Angeles |
| Relation Therapeutics | 2025 | Venture - Series Unknown | $26.0M | London |
| Vention | 2026 | Series D | $90.0M | Montréal |
| Ricursive Intelligence | 2026 | Series A | $300.0M | Palo Alto |
| Adaptive Security | 2025 | Series B | $81.0M | New York |
| PolyAI | 2025 | Series D | $86.0M | San Francisco |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | Seurat Technologies | Series C | $99.0M | Wilmington, United States |
| 27 | Evozyne | Series B | $81.0M | Chicago, United States |
| 28 | CHARM Therapeutics | Venture - Series Unknown | $20.0M | London, United Kingdom |
| 29 | vitrealab | Series A | $11.0M | Vienna, Austria |
| 30 | Freeform | Venture - Series Unknown | $58.9M | Los Angeles, United States |
| 31 | Relation Therapeutics | Venture - Series Unknown | $26.0M | London, United Kingdom |
| 32 | Vention | Series D | $90.0M | Montréal, Canada |
| 33 | Ricursive Intelligence | Series A | $300.0M | Palo Alto, United States |
| 34 | Adaptive Security | Series B | $81.0M | New York, United States |
| 35 | PolyAI | Series D | $86.0M | San Francisco, United States |
Seurat Technologies is a metal manufacturing focusing on a greener production.
Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
vitrealab unlocks Augmented Reality for everyday use, with its proprietary laser matrix photonic integrated circuit.
Freeform is a 3D printing company offering metal 3D printing solutions for manufacturing companies.
Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.
Vention is a digital manufacturing automation platform that helps companies automate their production floor.
Ricursive Intelligence uses AI and computing to shorten semiconductor timelines through recursive cycles designing silicon for AI.
Adaptive Security provides training and phishing simulations to help organizations strengthen human defenses against evolving cyber threats.
PolyAI develops conversational artificial intelligence software that enables organizations to automate customer service interactions.
Inception develops diffusion large language models for latency-sensitive applications.
Flexion Robotics develops an AI-driven autonomy platform for humanoid robots to enhance automation and space exploration.
NcodiN develops nanophotonic chips for data transport for processors that improves speed, energy efficiency and heating of the circuit
PhysicsX offers an AI-native simulation software stack for engineering and manufacturing across advanced industries.
Suno is a music-technology company that provides an AI-powered platform for generating original songs from simple text prompts.
WisdomAI develops an AI data analyst to answer questions from structured and unstructured data for business insights in the enterprise.
Oxa develops autonomous vehicle software and hardware solutions for industrial mobility automation.
Field AI develops autonomy software that equips mobile robots with a universal, risk-aware brain.
Emerald AI develops software that aligns AI data center workloads with real-time power grid conditions to manage energy use.
Samaya AI specializes in developing AI research agents that streamline knowledge workflows.
Machina Labs is a mechanical and industrial engineering and manufacturing company that automates metal forming and fabrication processes.
Lila Sciences creates a scientific superintelligence platform and autonomous labs for life sciences, chemistry, and materials science.
Proxima Bio develops programmable medicines that modulate protein interactions to address disease processes.
Simular is the autonomous computer company, one that creates AI-powered agents to automate how people use computers and the web.
NVentures has invested in 108 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
NVentures's top investment sectors include Artificial Intelligence (AI), Robotics, Software, Biotechnology, Life Science. The firm invests across 54 different industry categories.
Among tracked funding rounds, Ricursive Intelligence received $300.0M in a Series A round. NVentures's total known invested capital is $5.5B.
NVentures's average investment size is $81.5M across its portfolio of 108 companies.
Recent NVentures portfolio additions include Seurat Technologies, Evozyne, CHARM Therapeutics, vitrealab, Freeform. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors